Peter Altman

Peter Altman

Company: BioCardia

Job title: Chief Executive Officer


Clinical Development Synergies of Autologous and Allogeneic Bone Marrow Derived Cell Therapies for Ischemic Heart Failure 1:30 pm

CardiAMP Cell Therapy for Ischemic HFrEF Phase III Trial CardiALLO NK1R+ MSC Therapy for Ischemic HFrEF Phase I/II TrialRead more

day: Conference Day 1

A Hanson Wade Group Company

© Copyright 2023 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.